The size of the global allergy diagnostics market is expected to

New York, Oct. 24, 2022 (GLOBE NEWSWIRE) — announces the release of the report “Global Allergy Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Allergen, By Test Type, By Product & Services , by Regional Outlook and Forecast, 2022 – 2028” –
Skin allergies, food allergies, insect allergies, mold allergies, and drug allergies are some of the most common allergens. The type of allergy and the most appropriate treatment can also be determined by an allergy diagnostic test.

Allergy diagnostic techniques include skin tests, patch tests, intradermal tests, and blood tests. As pollution levels rise, the allergy diagnostics market is expected to grow. Major risk factors for chronic respiratory disease include occupational exposure, exposure to allergens, and exposure to indoor and outdoor air pollution.

Due to their greater exposure to environmental pollutants, city dwellers are more likely than rural dwellers to suffer from allergic disorders. The allergy diagnostics market is expected to grow due to the increase in food allergies. Cases of allergies are more common in urban areas than in rural areas. One of the most notable differences between these places is the degree of cleanliness and the potential for infectious diseases.

Early exposure to viral, bacterial and parasitic infections as well as exposure to a number of common microorganisms of the human body are expected to impact the development of the immune system. Climate change, air pollution, and the complexity of materials and cosmetics have all contributed to an increase in the prevalence of sensitive skin and its susceptibility to irritation. These elements are expected to fuel the allergy diagnostics market in the near future.

COVID-19 Impact Analysis

Due to the COVID-19 outbreak, there has been a slight reduction in the allergy diagnostics market. Since suffering patients are well informed on how to avoid likely environmental triggers and how to deal with acute events, also based on written action plans, diagnostic testing has been postponed in the majority of allergic disorders . However, once the pandemic was under control, diagnostic processes were restarted. To determine the impact of COVID-19 on allergy diagnostic testing services, several searches were conducted.

Market Growth Factors

Increased levels of environmental pollution

Major risk factors for developing chronic respiratory disorders include occupational exposure, exposure to allergens, and exposure to indoor and outdoor air pollution. Due to the greater exposure to environmental toxins in cities, the prevalence of allergic diseases is higher among urban residents than among rural residents (due to automobile pollution and industrial activities). Although it is a global phenomenon, its impacts are most severe in metropolitan areas of low-income countries, where more than 80% of people live in places where air quality levels exceed WHO safety guidelines.

Using mobile health to diagnose allergies

There are currently only a few mHealth tools for the diagnosis of allergic rhinitis (AR) that have been published in peer-reviewed publications, which limits the use of mHealth for the diagnosis of rhinitis. A new generation of point-of-care devices is being produced by recent advances in wireless communication, embedded biosensors, and energy harvesting techniques. However, RA is a very common disease all over the world. Advanced nasal inspiratory flow meters and intranasal biosensors are just two examples of diagnostic tools that can be connected to smartphones.

Market restraining factors

Allergy diagnostic instruments come at a high price

Market competitors regularly update a number of allergy diagnostic tools including luminometers, scanners, blot analyzers, ELISA analyzers, and immunoassay analyzers. These instruments cost more because they come with state-of-the-art features and functions (the cost of each instrument varies depending on its flexibility, accuracy, and TAT). Due to their substantial capital expenditures and ability to purchase large volume systems, large hospitals and diagnostic labs hold a larger share of the market.

End User Outlook

On the basis of end-user, the allergy diagnostics market is categorized into diagnostic laboratories, hospital laboratories, academic research institutes, and others. The hospital laboratory segment recorded a major revenue share in the allergy diagnostics market in 2021. There are a large number of hospitals operated by private and public authorities. The government largely supports this segment and thus increases the healthcare expenditure in hospital laboratories. These elements would further support the growth of the allergy diagnostics market in the coming years.

Allergen Outlook

By allergen, the allergy diagnostics market is divided into inhalant allergens, food allergens, drug allergens and other allergens. The inhaled segment held the largest revenue share in the allergy diagnostics market in 2021. Rising levels of pollen and environmental pollution, along with other factors such as dust, mold, and mushrooms, may be responsible for the rise of the allergy diagnostics market in the inhalant allergen segment. . These could all increase the consumer demand for inhalant allergens and thus accelerate the growth of the market over the forecast period.

Outlook quiz type

On the basis of test type, the allergy diagnostics market is segmented into in vitro and in vivo. The in vitro segment has acquired a substantial share of allergy diagnostics market revenue in 2021. The in vitro test is used to determine the presence of allergen-specific immunoglobulin E (IgE). An in vitro method for identifying allergen-specific antibodies of a new class of immunoglobulins, tentatively called IgND, is the radioallergosorbent test. The advantages of in vitro testing include its compatibility with any skin condition, no risk of systemic reaction, no steroid or antihistamine effects, and no compatibility issues.

Product and service outlook

On the basis of products and services, the allergy diagnostics market is fragmented into consumables, instruments, and services. In 2021, the consumables segment recorded the highest revenue share in the allergy diagnostics market. The increase in the number of allergies requiring rapid detection is one of the factors promoting the expansion of the market. Major market players across the globe are also collaborating strategically to provide consumers with better allergy diagnostics. These factors and strategic alliances by significant companies may contribute to the segments throughout the projection period.

Regional outlook

Regionally, the Allergy Diagnostics Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2021, the North America region led the allergy diagnostics market with the maximum revenue share. The growth of the regional market is mainly driven by the growing number of allergy sufferers, improved healthcare infrastructure, as well as advanced diagnostic technologies. As the number of pharmaceutical allergy-related deaths increases, the demand for timely and reliable allergy diagnosis will also increase.

The market research report covers the analysis of major market players. Key companies profiled in the report are Danaher Corporation, Hitachi Chemical Diagnostic Inc., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Thermo Fisher Scientific Inc., Neogen Corporation, Eurofins Scientific Group , and ACON Laboratories, Inc.

Scope of the study

Market Segments Covered in the Report:

Per end user

• Diagnostic laboratories

• University research institutes

• Laboratories in hospitals

• Others

By allergen

• Inhaled

• Medication

• Food

• Others

By type of test

• In Vivo

• In Vitro

By products and services

• Consumables

• Instruments

• Services

By geography

• North America

o United States

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o United Kingdom

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia-Pacific


o Brazil

o Argentina


o Saudi Arabia

o South Africa

o Nigeria

o Rest of the LAMEA

Profiled companies

• Danaher Corporation

• Hitachi Chemical Diagnostics Inc.

• Hycor Biomedical Inc.

• Lincoln Diagnostics Inc.

• Omega Diagnostic Llc

• Siemens Healthcare Diagnostics, Inc.

• Thermo Fisher Scientific Inc.

• Neogen Corporation

• Eurofins Scientific Group

• ACON Laboratories, Inc.

Unique offers

• Comprehensive coverage

• The largest number of tables and figures on the market

• Subscription-based model available

• Best price guaranteed

• Provided after-sales research support with 10% free customization
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


Previous Halloween spending set to rise by $500 million as candy prices rise at fastest pace ever
Next Fetterman and Oz meet for their only debate in high-stakes Senate race - WEIS